The 2024 U.S.-Taiwan Patient Care Innovation Forum, co-hosted by AmCham Taiwan and AIT, showcased significant advancements in healthcare technology, including expanded hemodialysis, IMVAD for heart failure, and precision radioligand therapy. Keynote speakers emphasized the need for evolving policies to support these innovations and align with Taiwan’s healthcare goals.
Eli Lilly is advancing treatments in oncology, diabetes, immunology, obesity, and Alzheimer’s disease, with new therapies on the horizon. In Taiwan, Lilly is addressing growing concerns about dementia and obesity with significant R&D investment and plans to conduct over 60 clinical trials in 2024.
The island’s manufacturing and technological strengths and trove of medical data make it well positioned to assume a significant role in biotech development and healthcare supply chains, but to do so, it must first surmount some longstanding obstacles. In the last year, the world has become painfully aware of the importance of supply chains in…
In an industry as dynamic and competitive as healthcare, standing out requires outstanding ingenuity, while still maintaining a dedication to patient wellbeing and care. For California-headquartered biopharmaceutical company Amgen, which last year celebrated 40 years of providing innovative and life-changing treatments to patients, being a leader is baked into its DNA. Over that period, 70%…
Robotic-assisted surgery has helped to advance the medical world, offering minimally invasive approaches that involve small incisions and increased precision. Compared to open surgery, such an approach can help accelerate the recovery process, depending on the procedure, and reduce the cost of care for patients and hospitals. Due to its many benefits, robotic-assisted surgery has…
Last May, research-based global biopharmaceutical firm AbbVie finalized a transformative acquisition of Allergan, an Ireland-headquartered healthcare solutions provider. The transaction made AbbVie, a relatively young spinoff of the long-established Abbott Laboratories, the fifth largest biopharmaceutical company in the world. It further diversified the company’s robust product portfolio, expanded and strengthened its already robust R&D pipeline,…
Finding effective solutions to the world’s health issues requires novel, holistic approaches and collaborative ingenuity. Healthcare companies must therefore increasingly shift their focus to the research and development of medical technologies, biopharmaceuticals, and innovative therapies to treat conditions and diseases that are difficult or nearly impossible to tackle using traditional medicines. Such a reality is…
Continuing the dialogue surrounding precision medicines and patient-centered care from a similar event three years earlier, the U.S.-Taiwan Innovative Patient-Centered Care Symposium, co-hosted by AmCham Taipei and the American Institute in Taiwan (AIT), took place at the AIT compound in Neihu on December 18. The aim of the event was to demonstrate the value of…
For Louis Ko, general manager of Johnson & Johnson Medical Taiwan, change is unavoidable. The Kellogg School of Management graduate has led the Taiwan affiliates of two multinational companies through big structural transitions, a major feat for anyone at any stage of their career. Ko says that being adaptable and adopting the right mindset were…
The battle against hepatitis has largely been won, but rising fatty liver incidence has worrisome implications. Mr. Lee and his wife have always been in fairly good health. Now well into their 60s, they still run a small tailor shop near Dongmen Market in Taipei. Both are slender and have never been overweight. To the…
